195 related articles for article (PubMed ID: 30065620)
41. Value of
Li S; Lin D; Tang M; Liu D; Lyu Q; Zhang J
J Gastrointest Oncol; 2022 Apr; 13(2):637-646. PubMed ID: 35557562
[TBL] [Abstract][Full Text] [Related]
42. Quantitative CT density histogram values and standardized uptake values of FDG-PET/CT with respiratory gating can distinguish solid adenocarcinomas from squamous cell carcinomas of the lung.
Tsubakimoto M; Yamashiro T; Tamashiro Y; Murayama S
Eur J Radiol; 2018 Mar; 100():108-115. PubMed ID: 29496067
[TBL] [Abstract][Full Text] [Related]
43. Assessment of cardiac tumors by
Meng J; Zhao H; Liu Y; Chen D; Hacker M; Wei Y; Li X; Zhang X; Kreissl MC
J Nucl Cardiol; 2021 Oct; 28(5):2233-2243. PubMed ID: 31933156
[TBL] [Abstract][Full Text] [Related]
44. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
[TBL] [Abstract][Full Text] [Related]
45. FDG PET using SUV
Huang YC; Lu HI; Huang SC; Hsu CC; Chiu NT; Wang YM; Chiu YC; Li SH
BMC Med Imaging; 2017 Jan; 17(1):1. PubMed ID: 28056868
[TBL] [Abstract][Full Text] [Related]
46. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis of pancreatic cancer using ¹⁸F-FDG PET/CT and CA19-9 with SUVmax association to clinical characteristics.
Sun Y; Duan Q; Wang S; Zeng Y; Wu R
J BUON; 2015; 20(2):452-9. PubMed ID: 26011335
[TBL] [Abstract][Full Text] [Related]
48. Clinical Effectiveness of Preoperative 18F-FDG PET/CT in Predicting Pathological Tumor Grade in Patients with Pseudomyxoma Peritonei Originating from Appendix: A Retrospective Cohort Study.
Aso K; Gohda Y; Hotta M; Minamimoto R; Shimizu Y; Uemura Y; Yano H
Ann Surg Oncol; 2024 Mar; 31(3):1990-1995. PubMed ID: 38082170
[TBL] [Abstract][Full Text] [Related]
49. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
50. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
Jung NY; Kim SH; Kang BJ; Park SY; Chung MH
Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608
[TBL] [Abstract][Full Text] [Related]
51. Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis.
Okazumi S; Dimitrakopoulou-Strauss A; Schwarzbach MH; Strauss LG
Hell J Nucl Med; 2009; 12(3):223-8. PubMed ID: 19936332
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the diagnostic efficacy of
Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
[TBL] [Abstract][Full Text] [Related]
53. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
[TBL] [Abstract][Full Text] [Related]
54. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
55. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
Dimitrakopoulou-Strauss A; Strauss LG; Schwarzbach M; Burger C; Heichel T; Willeke F; Mechtersheimer G; Lehnert T
J Nucl Med; 2001 May; 42(5):713-20. PubMed ID: 11337565
[TBL] [Abstract][Full Text] [Related]
56. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis.
Chen L; Wu X; Ma X; Guo L; Zhu C; Li Q
Medicine (Baltimore); 2017 Feb; 96(6):e5913. PubMed ID: 28178131
[TBL] [Abstract][Full Text] [Related]
58. A diagnostic model based on
Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X
BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331
[TBL] [Abstract][Full Text] [Related]
59. Functional image in soft tissue sarcomas: An update of the indications of
Rodríguez-Alfonso B; Simó-Perdigó M; Orcajo Rincón J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):233-243. PubMed ID: 32616457
[TBL] [Abstract][Full Text] [Related]
60. Correlation of [18F]FDG PET activity with expressions of Ki-67 in non-small-cell lung cancer.
Kucukosmanoglu I; Karanis MIE; Unlu Y; Erol M
Nucl Med Rev Cent East Eur; 2022; 25(2):73-77. PubMed ID: 36047292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
